Chemoinformaics analysis of 4-METHYL-1-PROPAN-2-YLBICYCLO[3.1.0]HEX-3-ENE-2-CARBALDEHYDE
Molecular Weight | 164.248 | nRot | 2 |
Heavy Atom Molecular Weight | 148.12 | nRig | 42 |
Exact Molecular Weight | 164.12 | nRing | 2 |
Solubility: LogS | -3.707 | nHRing | 0 |
Solubility: LogP | 5.218 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 29.8407 |
nHD | 0 | BPOL | 16.9193 |
QED | 0.258 |
Synth | 5.996 |
Natural Product Likeliness | 1.816 |
NR-PPAR-gamma | 0.016 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.999 |
Pgp-sub | 0.331 |
HIA | 0.011 |
CACO-2 | -5.388 |
MDCK | 0.0000248 |
BBB | 0.16 |
PPB | 0.748825 |
VDSS | 0.884 |
FU | 0.217176 |
CYP1A2-inh | 0.038 |
CYP1A2-sub | 0.968 |
CYP2c19-inh | 0.054 |
CYP2c19-sub | 0.973 |
CYP2c9-inh | 0.029 |
CYP2c9-sub | 0.647 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.952 |
CYP3a4-inh | 0.06 |
CYP3a4-sub | 0.961 |
CL | 8.338 |
T12 | 0.289 |
hERG | 0.98 |
Ames | 0.079 |
ROA | 0.419 |
SkinSen | 0.923 |
Carcinogencity | 0.028 |
EI | 0.004 |
Respiratory | 0.519 |
NR-Aromatase | 0.35 |
Antiviral | No |
Prediction | 0.797275 |